Pandion Therapeutics USPTO patents

Utility

Targeted Immunotolerance

10 Feb 22

Methods and compounds for conferring site-specific or local immune privilege.

Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane, Kevin Lewis Otipoby

Filed: 18 Sep 19

Utility

Targeted Immunotolerance

6 Jan 22

Methods and compounds for conferring site-specific or local immune privilege.

Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane

Filed: 10 Feb 21

Utility

d4963uw68bvyvc3k1iavrq69s

9 Sep 21

Methods and compounds for conferring site-specific or local immune privilege.

Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY

Filed: 20 Nov 18

Utility

lk4whqyqh91p5gbnrwf58qww93r9c1ebcz72yfw0m

2 Sep 21

Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.

Daniel Rios, Purvi Mande, Joanne L. Viney, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur, Salvatore Alioto, Lindsay J. Edwards

Filed: 18 Feb 21

Utility

jphj2o3tqxzymsrzhb2 7ouejg9m1nv1a0qk5p2ntb

17 Aug 21

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby

Filed: 25 Nov 19

Utility

43bvoqbina5ql0v3fanjmmu621z5wkvlulc3n0yc11p3

17 Aug 21

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby

Filed: 25 Nov 19

Utility

tzaextkmls05z2wlqt6ob98tauj 36rzm0ox7z1lo

8 Jul 21

Methods and polypeptides for conferring site-specific or local immune privilege.

Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Salvatore Alioto, Lindsay J. Edwards, Jacob Glanville, David Maurer, Sarah Ives, Sawsan Youssef, Devanshi Shanghavi, Lauren Schwimmer

Filed: 19 Aug 20

Utility

vplks4kbmedai4ll3et3n 8z7

1 Apr 21

Methods and compounds for conferring site-specific or local immune privilege.

Joanne L. Viney, Nathan Higginson-Scott

Filed: 24 Apr 20

Utility

bwsoheq7hnm cyj1ywc99h

30 Mar 21

Methods and compounds for conferring site-specific or local immune privilege.

Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane

Filed: 15 Mar 18

Utility

a14q5wg5465u6we2h7wynotdr7qcc8mc9regp6nh

16 Mar 21

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby

Filed: 28 Nov 18

Utility

apm88r9gcp q85oaeoeuq7

16 Dec 20

Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.

Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards, Erik Sampson, Jacob Glanville, David Maurer, Sarah Ives, Christina Pettus, Lauren Schwimmer

Filed: 19 May 20

Utility

fos596x34i7xay628vi3z57lpfr7mpnitshx5u7q

14 Oct 20

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby

Filed: 24 Nov 19

Utility

o8r qfwzg6wzdzgeiczbe0yb2

14 Oct 20

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby

Filed: 24 Nov 19